Create

Partnering, Deal Structuring & Negotiation
A small biotechnology company, with an innovative technology platform having applications across a variety of clinical areas, seeks funding to continue the development of their technology and to better position themselves for an IPO. Boston Healthcare is retained to identify those indications best suited for out-licensing. Utilizing a unique screening and assessment approach, Boston Healthcare identifies the optimal out-licensing opportunities. At the same time, Boston Healthcare initiates discussions with a large, multi-national pharmaceutical manufacturer and assists our client in closing a $25 million deal. This enables the company to continue R&D efforts and to enter the public market with greater credibility.

Assessing the Business Development Potential for a Bioinformatics Tool Company
Boston Healthcare worked with this life sciences knowledge management software company to outline a business development strategy. Our team examined market trends, competitor profiles, and opportunities in the drug discovery, clinical trials, and patient level informatics arenas. We then went on to develop and compare potential service/business models and probable deal structures and values for the business development group.

Strategic Mapping (Positioning) Research
Boston Healthcare worked with a biopharmaceutical company preparing for the launch of a pain management therapeutic. Boston Healthcare conducted qualitative research with potential prescribers to assess the impact of two potential strategic directions and to understand the opportunities and barriers associated with each potential scenario. Recommendations from this research led to in-depth, in-person research to test positioning “stories” and determine the key elements to be incorporated into the initial launch message.

Assessment of US Reimbursement Environment for Specialty Pharmaceuticals
A large oncology care provider needs to assess the evolving market for specialty pharmaceuticals. Boston Healthcare examines the approach payers take to manage specialty pharmaceuticals, and organizes these payers into a series of strategic “buckets” denoting their timelines and approaches to aggressive management. Boston Healthcare determines a key distinction between oncology agents, supportive care agents, and other specialty drugs with regard to levels and timing of management through specialty pharmacy or other options to physicians “buy and bill.” Boston Healthcare delivers a dollar volume projection of management strategies in a five year pro-forma.

Commercialization Strategies for Novel Clinical Diagnostics
Boston Healthcare has worked with many companies, both test developers and service providers in clinical diagnostics, to assess the market opportunity and develop strategies for market entry of new tests or services. These engagements typically examine everything from test or service market potential, to likely reimbursement milestones, adoption curve modeling, and product/service forecasts and financial plans.